Finally, we wrap up the belated April hires round-ups with our “pharma supplier” round-up inclusive of tech vendors, CROs, CDMOs, and others adjacent to the space.
Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh